Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
3 NC counties are under alert, including Johnston County.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Zymeworks Inc.
< Previous
1
2
3
Next >
Zymeworks Announces New Director Nominee
October 16, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 10, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
August 01, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks To Host Second Quarter 2023 Results Conference Call
July 19, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conference
July 03, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Appoints New Director
June 29, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes
June 26, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
June 01, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer
May 18, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 08, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
May 01, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks Presents New Data from Multiple Preclinical and Clinical Development Programs at the 2023 American Association for Cancer Research Annual Meeting
April 18, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
Zymeworks To Host First Quarter 2023 Results Conference Call
April 17, 2023
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors
April 10, 2023
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
April 03, 2023
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks to Present Updated Data on Multiple Product Candidates at the American Association for Cancer Research (AACR) Annual Meeting
March 14, 2023
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results
March 07, 2023
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
February 28, 2023
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks To Host Fourth Quarter And Full Year 2022 Results Conference Call
February 21, 2023
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
January 25, 2023
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2023
January 04, 2023
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conference
December 21, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Positive Topline Data in the Pivotal HERIZON-BTC-01 Trial of Zanidatamab
December 19, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zanidatamab Clinical Data Selected For Presentation At The American Society Of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
December 14, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
New Clinical Data for Zanidatamab in HER2+ /HR+ Metastatic Breast Cancer Presented Today at 2022 SABCS
December 09, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks to Transfer Stock Listing to Nasdaq
December 05, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Expiration of Hart-Scott-Rodino Waiting Period for Zanidatamab License Agreement with Jazz Pharmaceuticals
November 29, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Participation in Upcoming Investor Conference
November 22, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Announces Abstract For Zanidatamab In Late-Line HER2-Positive Hormone-Receptor Positive (HR+) Metastatic Breast Cancer At The San Antonio Breast Cancer Symposium (SABCS)
November 21, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
Zymeworks Provides Corporate Update and Reports Third Quarter 2022 Financial Results
November 08, 2022
From
Zymeworks Inc.
Via
Business Wire
Tickers
ZYME
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.